Rising Pharmaceuticals recalls
Rising Pharmaceuticals has 9 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 1 Mar 2023. 6 are still ongoing. The most frequent reason is nitrosamine impurity.
Total recalls9since 2019
Last 12 months0reported
Class I00% of total
Ongoing6latest 1 Mar 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 7 78%Class III 2 22%
Why rising pharmaceuticals is recalled
Product types
Brands
By year
Ongoing rising pharmaceuticals recalls
6 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg recalledMethylphenidate Hydrochloride | Rising Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Meclizine HCl Tablets, 25 mg recalled by Rising Pharmaceuticals | Rising Pharmaceuticals | Packaging Defects | NJ |
| Drug | CLASS II | Valsartan Tablets 160 mg recalled by Rising Pharmaceuticals | Rising Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan Tablets 80 mg recalled by Rising Pharmaceuticals | Rising Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan Tablets 320 mg recalled by Rising Pharmaceuticals | Rising Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan Tablets 40 mg USP, Rx, Only recalled by Rising Pharmaceuticals | Rising Pharmaceuticals | Nitrosamine Impurity | Nationwide |
All rising pharmaceuticals recalls, newest first
9 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.